Literature DB >> 25804681

[Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma: Description of a case and anesthetic implications].

M A Arteche Andrés1, O Zugasti Echarte2, J de Carlos Errea2, M Pérez Rodríguez2, R Leyún Pérez de Zabalza2, M A Azcona Calahorra2.   

Abstract

N-methyl-D-aspartate receptor encephalitis is an autoimmune encephalitis relationated or not with a neoplasm. Although its incidence is unknown, probably remains underdiagnosed. Epidemiological studies place it as the second cause of immune-mediated encephalitis and the first in patients aged less of 30 years. It shows neuropsychiatric symptoms and autonomic instability. After diagnosis, based on the detection of antibodies in serum or cerebrospinal fluid, an occult malignancy must be investigated. While increasing number of cases have been diagnosed and the important role of this receptor in general anesthesia mechanisms, the interaction of the disease with anesthetic agents and perioperative stress is unknown. We describe the case of a patient with encephalitis associated to ovarian teratoma that underwent gynaecological laparoscopy.
Copyright © 2014 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anestesia; Anesthesia; Anticuerpos antirreceptor N-metil-D-aspartato; Encefalitis; Encephalitis; N-methyl-D-aspartate receptor antibodies; Ovarian teratoma; Teratoma ovárico

Mesh:

Substances:

Year:  2015        PMID: 25804681     DOI: 10.1016/j.redar.2015.01.001

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim        ISSN: 0034-9356


  1 in total

1.  Anesthesia for patient with anti-N-methyl-D-aspartate receptor encephalitis: A case report with a brief review of the literature.

Authors:  Nozomi Wada; Kayoko Tashima; Akira Motoyasu; Harumasa Nakazawa; Joho Tokumine; Mieko Chinzei; Tomoko Yorozu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.